BlackRock
XGN icon

BlackRock’s Exagen XGN Stock Holding History

BlackRock’s Portfolio XGN Stock Details XGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$663K Buy
142,625
+16,739
+13% +$63K ﹤0.01% 4485
2026
Q1 		$378K Sell
125,886
-3,727
-3% -$14.4K ﹤0.01% 4596
2025
Q4 		$788K Buy
129,613
+47,246
+57% +$430K ﹤0.01% 4373
2025
Q3 		$905K Buy
82,367
+862
+1% +$7.63K ﹤0.01% 4309
2025
Q2 		$569K Buy
81,505
+48,098
+144% +$292K ﹤0.01% 4409
2025
Q1 		$120K Hold
33,407
– – ﹤0.01% 4726
2024
Q4 		$137K Hold
33,407
– – ﹤0.01% 4704
2024
Q3 		$103K Sell
33,407
-10,159
-23% -$26.3K ﹤0.01% 4662
2024
Q2 		$79.3K Sell
43,566
-11,939
-22% -$20.2K ﹤0.01% 4756
2024
Q1 		$88.3K Sell
55,505
-2,330
-4% -$4.52K ﹤0.01% 4763
2023
Q4 		$115K Sell
57,835
-9,235
-14% -$16K ﹤0.01% 4773
2023
Q3 		$162K Sell
67,070
-6,964
-9% -$17.7K ﹤0.01% 4731
2023
Q2 		$215K Buy
74,034
+1,811
+3% +$5.15K ﹤0.01% 4715
2023
Q1 		$176K Buy
72,223
+575
+0.8% +$1.49K ﹤0.01% 4814
2022
Q4 		$172K Sell
71,648
-2,193
-3% -$5.63K ﹤0.01% 4892
2022
Q3 		$200K Sell
73,841
-150
-0.2% -$837 ﹤0.01% 4971
2022
Q2 		$425K Sell
73,991
-497,322
-87% -$2.9M ﹤0.01% 4822
2022
Q1 		$4.59M Sell
571,313
-12,828
-2% -$111K ﹤0.01% 4015
2021
Q4 		$6.79M Buy
584,141
+253
+0% +$2.96K ﹤0.01% 3867
2021
Q3 		$7.94M Sell
583,888
-1,782
-0.3% -$23.7K ﹤0.01% 3778
2021
Q2 		$8.78M Buy
585,670
+324,932
+125% +$4.98M ﹤0.01% 3685
2021
Q1 		$4.56M Sell
260,738
-624
-0.2% -$11.1K ﹤0.01% 3982
2020
Q4 		$3.45M Buy
261,362
+38,728
+17% +$547K ﹤0.01% 3848
2020
Q3 		$2.41M Sell
222,634
-10,930
-5% -$141K ﹤0.01% 3855
2020
Q2 		$2.9M Buy
233,564
+70,543
+43% +$955K ﹤0.01% 3715
2020
Q1 		$2.6M Buy
163,021
+41,057
+34% +$815K ﹤0.01% 3576
2019
Q4 		$3.1M Buy
+121,964
New +$2.17M ﹤0.01% 3644

Other funds holding XGN

WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
NCNMGF
Nano-Cap New Millennium Growth Fund Staten Island, New York $130M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
SAM
Silvercrest Asset Management New York $15.3B AUM 40.56% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $5.65B AUM 61.31% 1-Year Est. Return
MBAM
Mink Brook Asset Management West Palm Beach, Florida $227M AUM 64.76% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return

BlackRock's XGN Position: Q2 2026 in Review

BlackRock increased its Exagen (XGN) stake by 13% in Q2 2026, buying an estimated $63K and bringing the position to 142,625 shares worth $663K. The position accounts for ﹤0.01% of the portfolio, ranked #4485.

BlackRock first reported a position in XGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $8.78M in Q2 2021. 57 funds tracked by Wall St. Rank hold XGN as of Q2 2026.

  • BlackRock held 142,625 shares of Exagen worth $663K as of Q2 2026.
  • BlackRock bought 16,739 Exagen shares in Q2 2026, an estimated $63K.
  • Exagen made up ﹤0.01% of BlackRock's portfolio in Q2 2026, its #4485 holding.
  • BlackRock first reported a position in Exagen in Q4 2019 and has held it in 27 quarters since.
  • BlackRock's Exagen position peaked at $8.78M in Q2 2021.
  • 57 funds tracked by Wall St. Rank held Exagen as of Q2 2026.

Based on BlackRock's 13F filing for Q2 2026, filed 7 Aug 2026.